Overview
Yuexing Tu practices practicing medicine in Hangzhou, China.
Their clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), Pseudomonas Stutzeri Infections, Sepsis, and COVID-19.
They are actively involved in clinical research, co-authoring 53 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yuexing X. Tu
Is Yuexing X. Tu a top-rated expert for Acute Respiratory Distress Syndrome (ARDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Yuexing X. Tu is classified as an Experienced expert for Acute Respiratory Distress Syndrome (ARDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yuexing X. Tu participate in research or clinical trials?
Yes. Yuexing X. Tu has published 53 articles and abstracts on conditions like Acute Respiratory Distress Syndrome (ARDS). You can view a list of Yuexing X. Tu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- COVID-19Tu isExperienced. Learn about COVID-19.
- Pseudomonas Stutzeri Infections
- SepsisTu isExperienced. Learn about Sepsis.